AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Renalytix Plc

6.37p +$0.47 (+8.05%)
LSE · 16 Sep 2026 11:59 UTC
Previous Close
5.95p
Day Range
5.5p6.37p
Year Range
1.6p11.75p
Market Cap
23.37M
AVG Volume
1.13M
Trailing/Forward PE
-0.33/35.91
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-03
Primary Exchange
London Stock ExchangeUK
Revenue (USD) · TTM
01M2M3M4M23 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q2
RENX.L Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
25 Q22.37M
25 Q12.35M
24 Q42.29M
24 Q32.22M
24 Q22.41M
24 Q12.89M
23 Q43.4M
23 Q33.72M
23 Q23.8M
23 Q13.46M
Net Income (USD) · TTM
-60M-40M-20M023 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q2
RENX.L Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
25 Q2-23.43M
25 Q1-28.03M
24 Q4-33.46M
24 Q3-37.49M
24 Q2-41.85M
24 Q1-43.81M
23 Q4-45.61M
23 Q3-39.66M
23 Q2-42.24M
23 Q1-47.12M
Operating Income (USD) · TTM
-60M-40M-20M023 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q2
RENX.L Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
25 Q2-19.19M
25 Q1-24.39M
24 Q4-29.19M
24 Q3-33.6M
24 Q2-38.38M
24 Q1-39.39M
23 Q4-42.22M
23 Q3-45.37M
23 Q2-48.98M
23 Q1-53.12M
EBITDA (USD) · TTM
-60M-40M-20M023 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q2
RENX.L EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
25 Q2-23.07M
25 Q1-23.79M
24 Q4-28.52M
24 Q3-32.87M
24 Q2-37.59M
24 Q1-38.88M
23 Q4-41.71M
23 Q3-41.26M
23 Q2-44.91M
23 Q1-49.06M
Cash Flows (USD) · TTM
-60M-40M-20M023 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q2
RENX.L Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
25 Q2-23.02M
25 Q1-24.45M
24 Q4-30.11M
24 Q3-30.92M
24 Q2-36.16M
24 Q1-36.47M
23 Q4-34.09M
23 Q3-39.41M
23 Q2-36.67M
23 Q1-42.81M
EPS (USD) · TTM
-0.8-0.6-0.4-0.2-023 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q2
RENX.L EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
25 Q2-0.22
25 Q1-0.27
24 Q4-0.33
24 Q3-0.4
24 Q2-0.46
24 Q1-0.51
23 Q4-0.56
23 Q3-0.56
23 Q2-0.62
23 Q1-0.69
Expenses (USD) · TTM
-20M020M40M60M80MR&DSG&ACapex23 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q2
RENX.L Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
25 Q215.11M
25 Q124.39M
24 Q429.05M
24 Q333.26M
24 Q238.23M
24 Q139.84M
23 Q443M
23 Q365.1M
23 Q269.1M
23 Q173.25M
Shares Outstanding (USD) · TTM
-8M-6M-4M-2M0Buybacks (Repurchases)Stock-Based Compensation23 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q2
RENX.L Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
25 Q2-1.42M
25 Q1-1.44M
24 Q4-1.71M
24 Q3-1.86M
24 Q2-2.31M
24 Q1-2.69M
23 Q4-2.93M
23 Q3-6.49M
23 Q2-6.31M
23 Q1-6.78M
Renalytix Plc
RENX.L
Stockpicker

Video analysis: RENX.L

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.